Improving your FEV1, the volume of air you can forcefully exhale in one second, comes down to a handful of strategies with real evidence behind them: quitting smoking, regular aerobic exercise, maintaining a healthy weight, targeted breathing exercises, and, for people with diagnosed lung conditions, the right medications. Some of these can measurably raise your FEV1 within weeks, while others work by slowing the decline that naturally accelerates with age. The mix that matters most depends on where you’re starting from and what’s dragging your numbers down.
Why FEV1 Declines and What That Means for You
Your lungs reach their peak function somewhere between age 20 and 25, and after that, a gradual decline begins that never fully reverses.1PubMed Central. Effect of aging on respiratory system physiology and immunology A systematic review of long-term cohort studies found that healthy adults lose roughly 18 to 46 milliliters of FEV1 per year, with a median around 22 mL per year in studies that followed people for a decade or more.2BMJ Open. Rate of normal lung function decline in ageing adults: a systematic review of prospective cohort studies Men tend to lose more in absolute terms (a median of about 44 mL per year) than women (about 31 mL per year), though the relative rate of change is similar for both. And the decline accelerates as the decades stack up.
For people with COPD, the picture is more aggressive. One community-based study found that older adults with mild to moderate COPD lost an average of about 66 mL per year, compared to about 43 mL per year in people without COPD.3npj Primary Care Respiratory Medicine. Annual decline rate in FEV1s in community-dwelling older adults diagnosed with mild to moderate COPD That faster loss underscores why the interventions below matter more for some people than others. Even modest improvements or slowdowns in decline can translate into years of better breathing.
Quit Smoking, Full Stop
If you smoke, this is the single most impactful thing you can do for your FEV1. A Greek cessation clinic study tracked smokers over multiple visits and found that those who successfully quit showed a statistically significant increase in FEV1, while those who kept smoking saw their FEV1 decrease over the same period.4PubMed Central. Association between smoking cessation and alterations in forced expiratory volume in one second (FEV1): A Follow-Up Study from a Greek Tobacco Cessation Clinic The effect isn’t trivial: a large Scandinavian study found that people who quit during the study period experienced a significantly slower rate of FEV1 decline compared to those who continued smoking, on the order of 15 to 21 mL per year slower depending on sex.5European Respiratory Journal. Smoking, changes in smoking habits, and rate of decline in FEV1: new insight into gender differences
Quitting doesn’t fully restore lung function that’s already been lost, but it bends the trajectory. Instead of your FEV1 plummeting along the accelerated path of a current smoker, it shifts back toward the gentler slope of a non-smoker. Over five, ten, or twenty years, that difference compounds enormously. And the benefit starts quickly: the cessation clinic data showed measurable FEV1 improvements within months of quitting, not years.
Aerobic Exercise
Regular cardio exercise is the most accessible tool for anyone looking to improve lung function, whether or not you have a diagnosed condition. A meta-analysis of studies in people with asthma found that aerobic exercise training significantly improved FEV1 along with other spirometry measures and quality-of-life scores.6PubMed Central. Effects of continuous aerobic exercise on lung function and quality of life with asthma: a systematic review and meta-analysis Another meta-analysis in asthma patients confirmed that aerobic exercise provided meaningful improvements in FEV1 capacity and cardiorespiratory endurance.7PubMed Central. A Meta Analysis of Physical Exercise on Improving Lung Function and Quality of Life Among Asthma Patients
The mechanism isn’t mysterious. Aerobic exercise strengthens the muscles involved in breathing, including the diaphragm and intercostals. It also improves how efficiently your cardiovascular system delivers oxygen, which reduces the demand on your lungs at any given activity level. In overweight and obese teenagers, aerobic training partially improved lung function by strengthening respiratory muscles, though the study noted that reaching predicted normal values required both longer training and weight loss.8PubMed Central. Effects of aerobic exercise on lung function in overweight and obese students
You don’t need to train at elite intensity. Brisk walking, cycling, swimming, and jogging all qualify. The common thread across the research is consistency: programs that ran for at least several weeks with multiple sessions per week produced the clearest improvements. A single workout won’t change your spirometry numbers, but a sustained habit will.
Breathing Exercises and Respiratory Muscle Training
Your respiratory muscles respond to targeted training the same way your biceps respond to curls. Inspiratory muscle training, where you breathe against a resistance device, has produced measurable gains in lung function even in people who are already fit. A study in combat-sport athletes found that six weeks of inspiratory muscle training raised FEV1 by about 4% and maximum voluntary ventilation by nearly 29%.9PubMed Central. The Effect of Inspiratory Muscle Training on The Pulmonary Function in Mixed Martial Arts and Kickboxing Athletes If training can push the needle in athletes, the potential for people starting from lower baselines is even more meaningful.
In children with bronchiectasis, 24 weeks of incremental-load respiratory muscle training significantly improved FEV1, FVC, and peak expiratory flow, along with the strength of the muscles themselves.10PubMed Central. Incremental Load Respiratory Muscle Training Improves Respiratory Muscle Strength and Pulmonary Function in Children with Bronchiectasis Resistance-based breathing devices are widely available without a prescription. They work by making your inspiratory muscles contract harder to pull air through a restricted opening, progressively building strength and endurance.
Yoga occupies a middle ground between general exercise and dedicated respiratory training, since many practices emphasize controlled, deep breathing. A meta-analysis of randomized controlled trials in clinical populations found that yoga significantly increased FEV1 by a weighted mean difference of 0.47 liters.11PubMed Central. Impact of yoga on pulmonary functions in clinical population: A systematic review and meta-analysis of randomized controlled trials (RCTs) A separate systematic review concluded that yogic practices improve not just spirometry values but also respiratory muscle strength in healthy, physically fit individuals.12PubMed. Effects of yogic intervention on pulmonary function and respiratory muscle strength parameters: A systematic literature review and meta-analysis A randomized trial specifically in bronchial asthma patients showed steady, progressive FEV1 improvement over eight weeks of a comprehensive yoga program.13PubMed Central. The efficacy of a comprehensive lifestyle modification programme based on yoga in the management of bronchial asthma: a randomized controlled trial
The takeaway: you don’t have to pick one approach. Aerobic exercise, resistance-based inspiratory training, and controlled breathing practices like yoga all improve lung function through somewhat different pathways, and there’s no reason you can’t combine them.
Losing Weight If You’re Carrying Extra
Excess body weight, especially around the abdomen, physically compresses the lungs and diaphragm. This restricts how much air you can move. Losing that weight reliably frees up lung volume. A study in obese adults found that for every one-unit drop in BMI through weight loss, FEV1 improved by an average of 1.5 percent predicted.14European Respiratory Journal. Effect of weight loss or gain on spirometry in obese adults That improvement was independent of how obese the person was to start with, meaning even people with moderate excess weight saw proportional gains.
After bariatric surgery, a study of 94 patients found significant improvement in FEV1 and FVC within three months. Interestingly, the reduction in waist circumference was the strongest predictor of lung function gains, more so than overall body weight loss.15PubMed. Surgically induced weight loss, including reduction in waist circumference, is associated with improved pulmonary function in obese patients A separate study in obese women found that weight loss significantly increased total lung capacity and functional residual capacity, essentially giving the lungs more room to expand.16PubMed Central. Effect of weight loss on operational lung volumes and oxygen cost of breathing in obese women
Weight gain, conversely, pushes FEV1 in the other direction. If you’re overweight and struggling with lung function, this is one area where the evidence is unusually clear-cut.
Medications for People With Diagnosed Conditions
If you have asthma or COPD, medications aren’t just symptom relief; they can measurably raise your FEV1. In COPD, combination inhalers that pair two types of long-acting bronchodilators have become the mainstay. A meta-analysis found that these dual-bronchodilator combinations improved trough FEV1 from baseline by about 70 to 80 mL more than either monotherapy or a different common combination, with patients significantly more likely to achieve a clinically meaningful improvement of over 100 mL.17PubMed Central. LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD: a systematic review and meta-analysis A separate network meta-analysis confirmed that all available fixed-dose bronchodilator combinations surpassed placebo for FEV1 improvement.18PubMed Central. A Network Meta-Analysis of Long-Acting Muscarinic Antagonist (LAMA) and Long-Acting β(2)-Agonist (LABA) Combinations in COPD
For asthma, inhaled corticosteroids remain foundational. A meta-analysis showed that even in people with mild intermittent asthma, inhaled corticosteroids significantly improved FEV1 and reduced airway hyperresponsiveness compared to placebo.19PubMed Central. Inhaled corticosteroids improve lung function, airway hyper-responsiveness and airway inflammation but not symptom control in patients with mild intermittent asthma: A meta-analysis Starting early matters: a trial in newly diagnosed asthma patients found that those randomized to inhaled budesonide had significantly smaller FEV1 declines at both one and three years compared to placebo.20PubMed. Effects of early intervention with inhaled budesonide on lung function in newly diagnosed asthma Delaying treatment doesn’t just mean more symptoms; it means more permanent loss of lung function.
If you’ve been prescribed an inhaler and you’re not using it consistently, improving your FEV1 may be as straightforward as actually taking the medication you already have.
Dietary Factors Worth Knowing About
Diet gets a lot of attention in popular health advice for lung function, but the evidence is more nuanced than the headlines suggest. Antioxidant-rich diets show associations with better lung function. A study in an Italian population found that women with the highest dietary antioxidant intake had FEV1 values about 39 mL higher than those with the lowest intake, an effect equivalent to about three years of lung aging. That finding held only in premenopausal women who had never smoked.21European Journal of Clinical Nutrition. Total dietary antioxidant capacity and lung function in an Italian population: a favorable role in premenopausal/never smoker women It’s an observational link, not proof that eating more berries will raise your FEV1, but it fits with broader research on oxidative stress and airway inflammation.
Omega-3 fatty acids are frequently promoted for lung health, but the evidence is shaky. A cross-sectional study of over 9,000 adults initially found that higher omega-3 intake was associated with better FEV1 and other measures, but after accounting for confounders like smoking, the association disappeared.22PubMed Central. Nutrition as a Modifiable Factor in Optimizing Respiratory Health: Evidence from Pulmonary Function Tests
Vitamin D is another popular recommendation. A randomized trial of monthly high-dose vitamin D supplements in adults found no significant improvement in lung function overall. However, in a subgroup of vitamin D-deficient participants who were current or former smokers, FEV1 increased by an average of 122 mL.23PubMed Central. Effect of Monthly, High-Dose, Long-Term Vitamin D on Lung Function: A Randomized Controlled Trial A separate trial in COPD patients found that vitamin D supplementation significantly improved FEV1 and reduced exacerbation frequency.24PubMed Central. Effects of Vitamin D Intake on FEV1 and COPD Exacerbation: A Randomized Clinical Trial Study So vitamin D supplementation is worth discussing with your doctor if you’re deficient, especially if you have COPD, but it’s not a blanket recommendation for everyone.
Reducing Your Exposure to Harmful Air
What you breathe in matters as much as what you breathe out. Occupational exposures to dusts, fumes, and solvents are associated with faster FEV1 decline. A systematic review and meta-analysis found that exposure to gases, fumes, and a category of mixed workplace vapors was significantly associated with accelerated FEV1 loss over time.25Occupational and Environmental Medicine. Ever and cumulative occupational exposure and lung function decline in longitudinal population-based studies: a systematic review and meta-analysis One study estimated that workers with likely dust exposure lost an extra 4.5 mL of FEV1 per year compared to unexposed individuals.26PubMed Central. Occupational exposures and longitudinal lung function decline Crystalline silica dust exposure was linked to significantly higher odds of airway obstruction in the general French population.27PubMed. The impact of occupational exposure to crystalline silica dust on respiratory function (airway obstruction and FEF(25-75)) in the French general population
If you work in construction, mining, manufacturing, or agriculture, proper respirator use and workplace ventilation aren’t just occupational safety theater. They protect FEV1 over a career’s worth of exposure.
Indoor air quality is a subtler factor. A study in young healthy adults found that HEPA air purifiers significantly improved FEV1 and other lung function measures by reducing indoor particulate matter.28PubMed. Effects of air purification of indoor PM(2.5) on the cardiorespiratory biomarkers in young healthy adults However, a systematic review looking specifically at indoor air filter use found no clear positive effect on FEV1 across pooled studies, whether people used filters for a few months or a full year.29PubMed Central. The Effect of Particulate Matter Reduction by Indoor Air Filter Use on Respiratory Symptoms and Lung Function: A Systematic Review and Meta-analysis The discrepancy likely reflects differences in baseline pollution levels and study design. Air purifiers are probably most helpful if you live somewhere with genuinely poor air quality or have existing respiratory sensitivity, and less likely to move the needle for someone in a clean-air environment with healthy lungs.
Airway Clearance Techniques
For people with conditions that cause mucus buildup, such as cystic fibrosis, bronchiectasis, or COPD with chronic bronchitis, getting that mucus out of the airways directly affects how much air can flow. Oscillatory positive expiratory pressure devices (the Flutter valve being the most well-known) work by creating vibrations in the airway that loosen mucus, making it easier to cough up. In patients hospitalized with cystic fibrosis flare-ups, use of a Flutter device produced higher FEV1 and FVC values after one week compared to traditional chest physical therapy.30Pediatric Pulmonology. Comparison of flutter device and chest physical therapy in the treatment of cystic fibrosis pulmonary exacerbation
In COPD patients, a randomized trial comparing a mucus clearance device to a sham device found that the active device improved FEV1 by about 60% at 120 minutes post-bronchodilator at baseline, compared to about 24% with the sham. The effect persisted after a week of regular use.31PubMed. A randomized trial to evaluate the sustained efficacy of a mucus clearance device in ambulatory patients with chronic obstructive pulmonary disease If you’re not producing significant mucus, these devices won’t do much for you. But if mucus is part of your problem, airway clearance is an underappreciated piece of the FEV1 puzzle.
Stress and Its Underestimated Effect on Breathing
Psychological stress can physically tighten your airways. In people with asthma, stress exposure caused measurable drops in FEV1, FVC, and peak expiratory flow compared to baseline, an effect that was not seen in healthy subjects.32PubMed. Protective effect of heart rate variability biofeedback on stress-induced lung function impairment in asthma The likely mechanism is autonomic nervous system dysfunction in asthma, where the body’s stress response triggers airway constriction more readily than it does in healthy lungs. That same study found that heart rate variability biofeedback, a technique where you learn to regulate your autonomic nervous system through controlled breathing cues, offered a protective effect against stress-induced lung function drops.
This isn’t a suggestion to meditate your way out of COPD. But for people with asthma who notice that their breathing worsens during stressful periods, the connection is physiologically real, and stress management techniques can reduce the degree to which stress triggers bronchoconstriction.
Genetic and Developmental Baselines
Not everyone starts from the same place, and not every low FEV1 is equally improvable. Research tracking participants from childhood into adulthood has shown that individuals with reduced FEV1 in early adulthood were already identifiable at ages 8 to 16, suggesting that developmental trajectories set during childhood strongly influence your adult baseline.33PubMed Central. Heterogeneity of reduced FEV(1) in early adulthood: A looking forward, looking backwards analysis Early-life factors like premature birth, childhood respiratory infections, and secondhand smoke exposure all influence the peak lung function you reach in your twenties, and once that peak is set, the interventions discussed here work relative to that ceiling.
There are also specific genetic conditions that affect the rate of lung function decline. Alpha-1 antitrypsin deficiency, a hereditary condition that damages lung tissue, leads to accelerated FEV1 loss. Augmentation therapy, which involves intravenous infusions of the missing protein, has been shown to slow FEV1 decline by roughly a quarter in meta-analysis, with the strongest benefit in patients whose lung function was moderately reduced.34PubMed. Augmentation therapy for alpha1 antitrypsin deficiency: a meta-analysis A separate large observational study found a significant slowing of FEV1 loss in treated patients whose FEV1 was between about 35 and 49 percent of predicted.35PubMed. Survival and FEV1 decline in individuals with severe deficiency of alpha1-antitrypsin If you have unexplained early-onset emphysema or a family history of lung disease at a young age, testing for this deficiency is worth pursuing.
Viral Infections and Long-Term Lung Health
Respiratory viral infections can leave lasting marks on lung function that persist well beyond the acute illness. Emerging research highlights the interplay between viral infections, the immune response, and changes in the bacterial communities living in the respiratory tract. Viral infections can alter the airway microbiota in ways that promote ongoing inflammation and epithelial damage, potentially contributing to chronic lung disease.36PubMed Central. Post-viral lung diseases: the microbiota as a key player In infants with cystic fibrosis, early respiratory viral infections were associated with significantly higher rates of bacterial colonization of the airways, including classic CF pathogens, suggesting that viruses can set the stage for further lung damage by disrupting the microbial balance.37Journal of Cystic Fibrosis. Early respiratory viral infections in infants with cystic fibrosis
For the average person, this means that protecting yourself from severe respiratory infections through vaccination, hand hygiene, and avoiding prolonged exposure to sick contacts isn’t just about avoiding a bad week. It’s about preserving the lung tissue you have. Post-infectious lung injury is an area of active research, and the mechanisms are still being worked out, but the pattern is consistent: viral damage to the airways can be a stepping stone to longer-term functional loss, especially in people who already have some degree of vulnerability.